1. Sharma, S. V., Bell, D. W., Settleman, J. & Haber, D. A. Epidermal growth factor receptor mutations in lung cancer. Nat. Rev. Cancer 7, 169–181 (2007).
2. Bareschino, M. A. et al. Treatment of advanced non small cell lung cancer. J. Thorac. Dis. 3, 122–133 (2011).
3. Shigematsu, H. et al. Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers. J. Natl. Cancer Inst. 98, 362–363 (2005).
4. Smith, G. D., Chadwick, B. E., Willmorepayne, C. & Bentz, J. S. Detection of EGFR gene mutations in cytology specimens from patients with non-small cell lung cancer utilizing high-resolution melting amplicon analysis. J. Clin. Pathol. 127, 1258–1262 (2007).
5. Kimura, T. et al. Clinical benefit of high-sensitivity KRAS mutation testing in metastatic colorectal cancer treated with anti-EGFR antibody therapy. Oncology 82, 298–304 (2012).